BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Denschlag D, Ackermann S, Battista MJ, Cremer W, Egerer G, Follmann M, Haas H, Harter P, Hettmer S, Horn LC, Juhasz-Boess I, Kast K, Köhler G, Kröncke T, Lindel K, Mallmann P, Meyer-Steinacker R, Mustea A, Petru E, Reichardt P, Schmidt D, Strauss HG, Tempfer C, Thiel F, Ulrich U, Vogl T, Vordermark D, Gass P, Beckmann MW. Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019). Geburtshilfe Frauenheilkd 2019;79:1043-60. [PMID: 31656317 DOI: 10.1055/a-0882-4116] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Dong X, Tan X, Zheng A, Guo T. High-grade endometrial stromal sarcoma with an extremely rapid progression: A rare case report. Asian Journal of Surgery 2022. [DOI: 10.1016/j.asjsur.2022.12.012] [Reference Citation Analysis]
2 Welz J, Moubarak M, Ataseven B, Heitz F, Harter P. Maligne mesenchymale Uterustumoren. Frauenheilkunde up2date 2022;16:517-533. [DOI: 10.1055/a-1749-1470] [Reference Citation Analysis]
3 Kumari S, Kumari P, Pankaj S, Rani J, Abhilashi K, Mishra A, Atreya K, Kumar D. Rare Mesenchymal Tumors of Cervix: A Report of Three Cases. Indian J Gynecol Oncolog 2022;20:57. [DOI: 10.1007/s40944-022-00666-5] [Reference Citation Analysis]
4 Huss A, Klar M, Hasanov MF, Juhasz-Böss I, Bossart M. Prognostic factors and survival of patients with uterine sarcoma: a German unicenter analysis. Arch Gynecol Obstet 2022. [PMID: 35780401 DOI: 10.1007/s00404-022-06515-2] [Reference Citation Analysis]
5 Yokoo S, Zeng F, Nogami M, Ueno YR, Murakami T. FDG PET/MRI in Synchronous Uterine Adenocarcinoma and Leiomyosarcoma. Clin Nucl Med 2022. [PMID: 35353760 DOI: 10.1097/RLU.0000000000004144] [Reference Citation Analysis]
6 Li K, Yin R, Li L, Wang D, Li L, Ma C, Ren Q, Wang G, Fan Y, Zhou H, Liu Z, Li T, Luo K, Kui D, Wang J. Diagnosis and treatment of uterine sarcoma: A multicenter, real-world study in western China. Medicine (Baltimore) 2021;100:e28220. [PMID: 34941084 DOI: 10.1097/MD.0000000000028220] [Reference Citation Analysis]
7 Travaglino A, Raffone A, Santoro A, Raimondo D, Improda FP, Cariati F, De Marco M, Casadio P, Seracchioli R, Zullo F, Insabato L, Zannoni GF. Risk of Recurrence in Uterine Leiomyoma with Bizarre Nuclei: a Systematic Review and Meta-Analysis. Geburtshilfe Frauenheilkd 2021;81:1217-23. [PMID: 34754271 DOI: 10.1055/a-1533-1651] [Reference Citation Analysis]
8 Li L, Huang W, Xue K, Feng L, Han Y, Wang R, Gao J. Clinical and imaging features of carcinosarcoma of the uterus and cervix. Insights Imaging 2021;12:142. [PMID: 34674042 DOI: 10.1186/s13244-021-01084-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Nseir L, Mansour G, Makhoul J, Skaf L, Dahhan MZ, AlShehabi Z. Low-Grade Endometrial Stromal Sarcoma in a 22-Year-Old Maiden Female: A Rare Case Report from Syria. Case Rep Obstet Gynecol 2021;2021:5578686. [PMID: 34327030 DOI: 10.1155/2021/5578686] [Reference Citation Analysis]
10 Fantappiè G, Malentacchi F, Turrini I, Sorbi F, Castiglione F, Vergoni F, Ammatuna C, Antonuzzo L, Fambrini M, Noci I, Pillozzi S. Detection of PIK3CA E545A mutation in circulating tumor DNA of a patient affected by uterine carcinosarcoma. Anticancer Drugs 2020;31:880-3. [PMID: 32796408 DOI: 10.1097/CAD.0000000000000959] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Kyriazoglou A, Liontos M, Ntanasis-Stathopoulos I, Gavriatopoulou M. The systemic treatment of uterine leiomyosarcomas: A systematic review. No news is good news? Medicine (Baltimore) 2021;100:e25309. [PMID: 33787622 DOI: 10.1097/MD.0000000000025309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ayhan A, Gungorduk K, Khatib G, Fırat Cüylan Z, Boran N, Gökçü M, Çelik H, Özgül N, Akbayir Ö, Şimşek T, Bakay A, Faruk Köse M, Tunç M, Küçükgöz Güleç Ü, Koç S, Kuşçu E, Vardar MA, Akilli H, Taskiran C, Mutlu Meydanlı M. Prognostic factors and survival outcomes of women with uterine leiomyosarcoma: A Turkish Uterine Sarcoma Group Study-003. Curr Probl Cancer 2021;:100712. [PMID: 33685725 DOI: 10.1016/j.currproblcancer.2021.100712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Zizolfi B, Foreste V, Di Spiezio Sardo A, Manzi A, Bifulco G, Carugno J. Fertility sparing management of uterine adenosarcoma: Case report and literature review. Facts Views Vis Obgyn 2021;12:315-8. [PMID: 33575681] [Reference Citation Analysis]
14 Batra Modi K. Uterine Sarcomas: Review and Update. Recent Advances in Endometrial Cancer 2020. [DOI: 10.1007/978-981-15-5317-2_16] [Reference Citation Analysis]
15 Lee WL, Chan IS, Wang PH. Uterine sarcoma: An unusual but high lethal disease of gynecological malignancies. J Chin Med Assoc 2020;83:213-4. [PMID: 31868858 DOI: 10.1097/JCMA.0000000000000242] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]